PT96400A - Processo de preparacao de composicoes farmaceuticas a base de complexos de acido quinolona-carboxilico-iao metalico-acido - Google Patents

Processo de preparacao de composicoes farmaceuticas a base de complexos de acido quinolona-carboxilico-iao metalico-acido

Info

Publication number
PT96400A
PT96400A PT96400A PT9640090A PT96400A PT 96400 A PT96400 A PT 96400A PT 96400 A PT96400 A PT 96400A PT 9640090 A PT9640090 A PT 9640090A PT 96400 A PT96400 A PT 96400A
Authority
PT
Portugal
Prior art keywords
acid
quinolone
carboxylic acid
metalico
iao
Prior art date
Application number
PT96400A
Other languages
English (en)
Other versions
PT96400B (pt
Inventor
Laman A Al-Razzak
Francisco J Alvarez
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23822659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT96400(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PT96400A publication Critical patent/PT96400A/pt
Publication of PT96400B publication Critical patent/PT96400B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C07F5/069—Aluminium compounds without C-aluminium linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT96400A 1989-12-29 1990-12-28 Processo de preparacao de composicoes farmaceuticas a base de complexos de acido quinolona-carboxilico-iao metalico-acido PT96400B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45892789A 1989-12-29 1989-12-29

Publications (2)

Publication Number Publication Date
PT96400A true PT96400A (pt) 1991-10-15
PT96400B PT96400B (pt) 1998-06-30

Family

ID=23822659

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96400A PT96400B (pt) 1989-12-29 1990-12-28 Processo de preparacao de composicoes farmaceuticas a base de complexos de acido quinolona-carboxilico-iao metalico-acido

Country Status (14)

Country Link
US (1) US5334589A (pt)
EP (1) EP0507851B1 (pt)
JP (1) JP3153549B2 (pt)
AT (1) ATE150973T1 (pt)
AU (1) AU647772B2 (pt)
CA (1) CA2072366C (pt)
DE (1) DE69030387T2 (pt)
DK (1) DK0507851T3 (pt)
ES (1) ES2102393T3 (pt)
GR (1) GR3023542T3 (pt)
IE (1) IE904725A1 (pt)
IL (1) IL96776A (pt)
PT (1) PT96400B (pt)
WO (1) WO1991009525A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118183D0 (en) * 1991-08-23 1991-10-09 Solanki Kishor K Imaging of infections
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US6024979A (en) * 1995-06-06 2000-02-15 Solvay Animal Health, Inc. Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant
IL124454A (en) * 1995-12-21 2003-10-31 Pfizer Injectable danofloxacin formulations
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE10018781A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Infusionslösungen des Ciprofloxacins mit verbesserter Lagerfähigkeit
KR20070029280A (ko) * 2004-07-02 2007-03-13 다이이찌 세이야꾸 가부시기가이샤 퀴놀론 함유 의약 조성물
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
ES2809177T3 (es) 2008-10-07 2021-03-03 Horizon Orphan Llc Inhalación de levofloxacino para reducir la inflamación pulmonar
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
CA2773033C (en) 2009-09-04 2016-10-11 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis
WO2016195021A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
US10617684B2 (en) 2015-06-02 2020-04-14 Kyorin Pharmaceutical Co., Ltd. Aqueous drug
EP3305295A4 (en) 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE
CN105524060B (zh) * 2016-03-10 2017-03-22 青岛云天生物技术有限公司 一种制备盐酸莫西沙星的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
JP2832535B2 (ja) * 1989-04-04 1998-12-09 富山化学工業株式会社 キノロンカルボン酸またはその塩の可溶化法
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.

Also Published As

Publication number Publication date
EP0507851A4 (en) 1993-03-17
CA2072366A1 (en) 1991-06-30
AU7153191A (en) 1991-07-24
CA2072366C (en) 2002-08-20
ATE150973T1 (de) 1997-04-15
ES2102393T3 (es) 1997-08-01
IE904725A1 (en) 1991-07-17
JPH05502879A (ja) 1993-05-20
JP3153549B2 (ja) 2001-04-09
IL96776A0 (en) 1991-09-16
IL96776A (en) 1997-02-18
EP0507851A1 (en) 1992-10-14
EP0507851B1 (en) 1997-04-02
PT96400B (pt) 1998-06-30
DE69030387T2 (de) 1997-10-23
DE69030387D1 (de) 1997-05-07
US5334589A (en) 1994-08-02
DK0507851T3 (da) 1997-08-25
AU647772B2 (en) 1994-03-31
WO1991009525A1 (en) 1991-07-11
GR3023542T3 (en) 1997-08-29

Similar Documents

Publication Publication Date Title
PT96400A (pt) Processo de preparacao de composicoes farmaceuticas a base de complexos de acido quinolona-carboxilico-iao metalico-acido
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ES2001512A6 (es) Procedimiento para la fabricacion de esteres totales y parciales del acido hialuronico
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
MY110734A (en) Improvements in or relating to dioic acids.
ATE135577T1 (de) Verwendung von buspiron zur herstellung eines pharmazeutischen präparats zur behandlung der alkoholsucht
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
KR950005823A (ko) 5-아미노-8-메틸-7-피롤리디닐퀴놀린-3-카르본산유도체
DE3880587D1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
HUT45521A (en) Process for producing quinolinecarboxylic acid derivatives
ES2066134T3 (es) Usos farmaceuticos de acidos grasos.
EP0354568A3 (en) Novel catechol derivatives
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
HUT46212A (en) Process for production of antibacterial liofilized compounds
IE873463L (en) Compositions
DE60015306D1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
NO930083L (no) Sammensetning for behandling av alzheimers sykdom og fremgangsmaate for fremstilling av samme
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910531

FG3A Patent granted, date of granting

Effective date: 19980327

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130327